Mikko Neuvonen

University of Helsinki — Finland

Medicine · Health Sciences

48h-index7.2kcitations133works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(50), Pharmacogenetics and Drug Metabolism(47), Pharmacological Effects and Toxicity Studies(28), Antiplatelet Therapy and Cardiovascular Diseases(16), Lipoproteins and Cardiovascular Health(15)

Publications133 total

In vitro inhibition of organic anion transporting polypeptide 2B1 (OATP2B1) is common among marketed drugs
European Journal of Pharmaceutical Sciences·2026Open Access
Distinct fasting and postprandial bile acid responses following Roux-en-Y and one-anastomosis gastric bypass
International Journal of Obesity·2026Open Access
Repeated Intake of Grapefruit Juice Inhibits <scp>CYP2B6</scp> , <scp>CYP2C9</scp> , <scp>CYP2C19</scp> , and <scp>CYP3A4</scp> while Lingonberry Powder Does Not Induce Major <scp>CYP</scp> Enzymes in Humans
Clinical Pharmacology & Therapeutics·2025Open Access
Corrigendum to “Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitro” [European Journal of Pharmaceutical Sciences 215 (2025) 107322]
European Journal of Pharmaceutical Sciences·2025Open Access
Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitro
European Journal of Pharmaceutical Sciences·2025Open Access
Systemic N‐Acylethanolamines and Other Lipid Mediators Are Associated With <scp>NSAID</scp> ‐Exacerbated Respiratory Disease
Clinical & Experimental Allergy·2025Open Access
A seven cytochrome P450 index substrate cocktail for clinical trials – Profiling the effects of clopidogrel and gemfibrozil on CYP enzymes and OATP1B1 biomarkers
Drug Metabolism and Pharmacokinetics·2025
Non-targeted metabolomics for the identification of biomarker candidates for breast cancer resistance protein
Drug Metabolism and Pharmacokinetics·2025
Comparative uptake of statins by hepatic organic anion transporting polypeptides
European Journal of Pharmaceutical Sciences·2025· 6 citedOpen Access
Transport of statins by multidrug resistance-associated proteins 1 and 5
European Journal of Pharmaceutical Sciences·2025· 2 citedOpen Access
Identification of Genetic Variants Associated with Pravastatin and Pitavastatin Pharmacokinetics
Clinical Pharmacology & Therapeutics·2025· 3 citedOpen Access
Genetic and Functional Characterization of <i>DPYD</i> Exon 4 Deletion Common in the Finnish Population
Basic & Clinical Pharmacology & Toxicology·2025· 1 citedOpen Access
A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil
Clinical Pharmacology & Therapeutics·2025· 2 citedOpen Access
Accumulation of altered serum bile acids predicts liver injury after portoenterostomy in biliary atresia
Journal of Hepatology·2025· 10 citedOpen Access
Candesartan Has No Clinically Meaningful Effect on the Plasma Concentrations of Cytochrome P450 2C8 Substrate Repaglinide in Humans
Drug Metabolism and Disposition·2024· 3 citedOpen Access
Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing
Clinical Pharmacokinetics·2024· 4 citedOpen Access
In vitro assessment of inhibitory effects of kinase inhibitors on CYP2C9, 3A and 1A2: Prediction of drug-drug interaction risk with warfarin and direct oral anticoagulants
European Journal of Pharmaceutical Sciences·2024· 6 citedOpen Access
Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4
Clinical Pharmacology & Therapeutics·2024· 7 citedOpen Access
Genome‐Wide Association Study of Atorvastatin Pharmacokinetics: Associations With <i>SLCO1B1</i>, <i>UGT1A3</i>, and <i>LPP</i>
Clinical Pharmacology & Therapeutics·2024· 10 citedOpen Access
Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide <scp>1B1</scp> function
Clinical and Translational Science·2024· 5 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Pertti J. Neuvonen(47), Mikko Niemi(28), Janne T. Backman(28), Jouko Laitila(9), Klaus T. Olkkola(9), Aleksi Tornio(8), Teijo I. Saari(7), Kari Laine(7), Nora Hagelberg(6), Kari T. Kivistö(5), Tuija H. Nieminen(5), Annikka Kalliokoski(5), Carl Kyrklund(3), Michel Eichelbaum(3), Lauri Kajosaari(3), Anne M. Filppula(3), Marja K. Pasanen(2), Matthias Schwab(2), Marika T. Granfors(2), Harri Luurila(2)